Keros Therapeutics (KROS) News Today
KROS rose 1.50% in the 10 minutes after this headline crossed at 16:01:52 ET on Monday, Nov 16:
Keros Therapeutics authorizes a $5 million common-stock buyback after receiving a $20 million development milestone payment from Takeda Pharmaceuticals
Price 10.03 two minutes before the headline, 10.18 10 minutes after it.
Latest headline on this page:
Ask ChatGPT about KROSAsk Claude about KROSConnect MoveSurge to your assistant
1 headline on Keros Therapeutics appeared in our news feed in the last 7 days with a measured price reaction attached. 1 of them moved the underlying at least 0.35% in the minutes after the headline crossed. The largest measured reaction was +1.50% over 10 minutes on KROS, after the headline at Nov 16, 16:01:52 ET.
Price action when the news broke
16:01:52 ET
What moved KROS — last 7 days
| Time | Headline | 1 min | Reaction |
|---|---|---|---|
| Nov 16, 16:01:52 ET | Keros Therapeutics authorizes a $5 million common-stock buyback after receiving a $20 million development milestone payment from Takeda Pharmaceuticals | +2.59% | +1.50% · 10m |
Moves are measured against the price two minutes before each headline crossed, using validated 1-minute bars captured at publish time. A dash means no bar was available for that window. Reaction pending means the measuring window for that headline is still open. Not attributed means the headline does not name the company the move was measured on, so we hold the number back. Times are New York ET. Headlines appear here 15 minutes after they cross the live tape.